Analytical Data
-
基因名
LOH12CR1
- Application
-
别名
BORCS5; LOH12CR1BLOC-1-related complex subunit 5; Loss of heterozygosity 12 chromosomal region 1; Myristoylated lysosomal protein; Myrlysin
-
种属
Human
-
表达系统
E. coli
-
标签
GST-tag at N-terminal
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q969J3
-
表达区间
1-196aa
-
氨基酸序列
MGSEQSSEAESRPNDLNSSVTPSPAKHRAKMDDIVVVAQGSQASRNVSNDPDVIKLQEIPTFQPLLKGLLSGQTSPTNAKLEKLDSQQVLQLCLRYQDHLHQCAEAVAFDQNALVKRIKEMDLSVETLFSFMQERQKRYAKYAEQIQKVNEMSAILRRIQMGIDQTVPLLDRLNSMLPEGERLEPFSMKPDRELRL
-
分子量
48.6 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
LOH12CR1 is a protein identified in recent studies as a potential therapeutic target due to its involvement in various biological processes, including immune responses and cellular differentiation. Research into LOH12CR1 has garnered attention because it is believed to play a crucial role in cancer biology, particularly in mediating tumor progression and metastasis. The understanding of its structure and function is vital for the development of new treatment strategies, as it may influence the behavior of cancer cells and their interaction with the surrounding microenvironment. Advances in recombinant protein technology allow for the production of LOH12CR1, enabling researchers to investigate its properties and effects in vitro and in vivo. This recombinant protein serves as a key tool in elucidating the mechanisms underlying its function and potential implications in disease. Ongoing research aims to clarify the pathways associated with LOH12CR1, with the hope that insights gained could lead to novel approaches in cancer therapy and enhance our comprehension of its role in cellular physiology.
